Holger W. Auner
- Molecular Biology
- Oncology top 5%
- Hematology top 2%
- Epidemiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Heinz SillWerner LinkeschHartmut LinkRobert KrauseChristoph TinchonFranz QuehenbergerAndreas TiranSimone Cenci
- Topics
- Multiple Myeloma Research and Treatments (37 papers)Protein Degradation and Inhibitors (23 papers)Cancer Treatment and Pharmacology (11 papers)
- Partner nations
- United KingdomAustriaUnited States
In The Last Decade
Holger W. Auner
82 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 677
- Oncology 619
- Hematology 566
- Epidemiology 285
- Cardiology and Cardiovascular Medicine 186
Countries citing papers authored by Holger W. Auner
This map shows the geographic impact of Holger W. Auner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger W. Auner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger W. Auner more than expected).
Fields of papers citing papers by Holger W. Auner
This network shows the impact of papers produced by Holger W. Auner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger W. Auner. The network helps show where Holger W. Auner may publish in the future.
Co-authorship network of co-authors of Holger W. Auner
This figure shows the co-authorship network connecting the top 25 collaborators of Holger W. Auner. A scholar is included among the top collaborators of Holger W. Auner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger W. Auner. Holger W. Auner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 20 | |
| 7 | 2 | |
| 8 | 16 | |
| 9 | 28 | |
| 10 | 26 | |
| 11 | 13 | |
| 12 | 38 | |
| 13 | 72 | |
| 14 | 12 | |
| 15 | 4 | |
| 16 | 22 | |
| 17 | 22 | |
| 18 | 4 | |
| 19 | 11 | |
| 20 | 51 |
About Holger W. Auner
Holger W. Auner is a scholar working on Hematology, Oncology and Clinical Biochemistry, having authored 87 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), Protein Degradation and Inhibitors (23 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Hematology (566 citations), Oncology (619 citations) and Clinical Biochemistry (109 citations). Holger W. Auner has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Heinz Sill, Werner Linkesch, Hartmut Link, Robert Krause, Christoph Tinchon, Franz Quehenberger, Andreas Tiran, Simone Cenci, Niall Dillon and Pierangela Sabbattini. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.